The company’s internal strain, including reports of required long working hours, is overshadowing its push for a U.S. listing.Finance, Hong Kong, IPOs, NewsRead More

You might also be interested in reading Bayer AG Non-GAAP EPS of €2.49, revenue of €13.74B; updates FY25 outlook.